FDA-Drug2021-03-03Class II
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
The General Hospital Corporation
Hazard
Lack of Assurance of Sterility
Sold states
Product was distributed to one direct account.
Affected count
50 mL vial
Manufactured in
55 Fruit St, N/A, Boston, MA, United States
Products
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0288-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief